Community protocol

Morning Daily

Testosterone

235 lbs

71 in

male

By

John

Weight

GLP-3

Metabolic

Longevity

mot

Metabolic

Weight

cjci

Growth

For research purposes only.

Peptide Mind does not endorse this protocol. This is a user-generated research reference — not for human consumption or therapeutic use.

Log your research schedule

Add this research protocol to your calendar or print a reference copy for your lab records. For research purposes only.

Peptide Protocol Schedule

A day-by-day view of this protocol. Tap any day to see which peptides are active. Circle size reflects how many peptides are scheduled; colored dots below represent individual peptides.

July 2026

Sun

Mon

Tue

Wed

Thu

Fri

Sat

28

29

30

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

1

mot

MOTS-c

morning

subcutaneous

2 mg

cjci

CJC-1295 (No Dac)/Ipamorelin

evening

subcutaneous

350 mcg

Daily Dosing Breakdown

A grouped breakdown of which peptides to take throughout this protocol. Consecutive days with the same schedule are combined. Days with no doses are omitted.

Jul 14–16, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 17, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 18–23, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 24, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 25–30, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 31, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 1–6, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 7, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 8–13, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 14, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 15–20, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 21, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 22–27, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 28, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 29 – Sep 3, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 4, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 5–10, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 11, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 12–17, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 18, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 19–24, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 25, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 26 – Oct 1, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 2, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 3–8, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 9, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 10–15, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 16, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 17–22, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 23, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 24–29, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 30, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 31 – Nov 5, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 6, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 7–12, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 13, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 14–19, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 20, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 21–26, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 27, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 28 – Dec 3, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 4, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 5–10, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 11, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 12–17, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 18, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 19–24, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 25, 2026

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 26–31, 2026

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 1, 2027

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 2–7, 2027

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 8, 2027

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 9–14, 2027

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 15, 2027

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 16–21, 2027

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 22, 2027

GLP-3 — 4 mg · Morning

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 23–26, 2027

MOTS-c — 2 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 27–28, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 29, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 30 – Feb 4, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 5, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 6–11, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 12, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 13–18, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 19, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 20–25, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 26, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Feb 27 – Mar 4, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 5, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 6–11, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 12, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 13–18, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 19, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 20–25, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 26, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Mar 27 – Apr 1, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 2, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 3–8, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 9, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 10–15, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 16, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 17–22, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 23, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 24–29, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Apr 30, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 1–6, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 7, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 8–13, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 14, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 15–20, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 21, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 22–27, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 28, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

May 29 – Jun 3, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 4, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 5–10, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 11, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 12–17, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 18, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 19–24, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 25, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jun 26 – Jul 1, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 2, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 3–8, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 9, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 10–15, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 16, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 17–22, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 23, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 24–29, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 30, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jul 31 – Aug 5, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 6, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 7–12, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 13, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 14–19, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 20, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 21–26, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 27, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Aug 28 – Sep 2, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 3, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 4–9, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 10, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 11–16, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 17, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 18–23, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 24, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Sep 25–30, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 1, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 2–7, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 8, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 9–14, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 15, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 16–21, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 22, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 23–28, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 29, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Oct 30 – Nov 4, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 5, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 6–11, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 12, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 13–18, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 19, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 20–25, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 26, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Nov 27 – Dec 2, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 3, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 4–9, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 10, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 11–16, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 17, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 18–23, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 24, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 25–30, 2027

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Dec 31, 2027

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 1–6, 2028

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 7, 2028

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 8–13, 2028

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 14, 2028

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 15–20, 2028

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 21, 2028

GLP-3 — 4 mg · Morning

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Jan 22–26, 2028

CJC-1295 (No Dac)/Ipamorelin — 350 mcg · Evening

Weekly Schedule

Day-of-week breakdown for each peptide in this protocol.

Mon

Tue

Wed

Thu

Fri

Sat

Sun

GLP-3

GLP-3

morning

subcutaneous

4 mg

Cycle Duration: 80 weeks

Total Peptide Requirements

The total quantity of each peptide needed to complete this protocol, calculated from dosage and duration.

Weight

GLP-3

Metabolic

GLP-3

4 mg · weekly · Morning

320

Metabolic

mot

Metabolic

MOTS-c

2 mg · 7× weekly · Morning

394

Growth

cjci

Growth

CJC-1295 (No Dac)/Ipamorelin

0.35 mg · 7× weekly · Evening

196.7

Know exactly what to draw

Enter your vial concentration and we'll calculate the precise injection volume for every peptide in this protocol.

Calculate dosage

Protocol Body Targets

The biological systems and tissue targets addressed by the 3 peptides in this protocol.

4

Body Targets

3 peptides

Metabolic

Regulates fat metabolism, insulin sensitivity, and energy use.

GLP-3, MOTS-c

Gut

Supports gut lining integrity, digestion, and the gut-brain axis.

GLP-3

Muscle

Enhances muscle growth, repair, and recovery after exercise.

MOTS-c, CJC-1295 (No Dac)/Ipamorelin

Hormones

Influences hormone signaling pathways and endocrine balance.

CJC-1295 (No Dac)/Ipamorelin

Build your own protocol

Create a custom peptide stack tailored to your goals. Add peptides, set dosages, and share it with the community.

Protocol Duration & Timeline

A visual breakdown of each peptide's active window within this protocol. Use this to understand the total cycle length and how each compound's duration compares to the full protocol.

GLP-3
4 mg once per week: 560 days
MOTS-c
2 mg 7x per week: 197 days
CJC-1295 (No Dac)/Ipamorelin
350 mcg 7x per week: 562 days

Protocol Peptides

Each peptide included in this protocol with its dosing amount, frequency, and administration details.

Weight

GLP-3

Metabolic

Preclinical

WeightMetabolic

Metabolic

mot

Metabolic

Phase 1

LongevityMetabolic

Growth

cjci

Growth

CJC-1295 (No Dac)/Ipamorelin

Experimental

Build your own protocol

Create a custom peptide stack tailored to your goals. Add peptides, set dosages, and share it with the community.

Browse other protocols

Body Recomp49 days

Weekly Stack

4

Weight

ser

Longevity

nad

Weight

GLP-3

Healing

4

Weight

GLP-3

Healing

core

Skin

MT-1

Performance102 days

Ascension Stack

Nick

3

Healing

ghk

Weight

GLP-3

Healing

klow

Performance28 days

tori

1

Longevity

mot

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringe units to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.